Semisynthetic neoclerodanes as kappa opioid receptor probes.
Kimberly M Lovell, Tamara Vasiljevik, Juan J Araya, Anthony Lozama, Katherine M Prevatt-Smith, Victor W Day, Christina M Dersch, Richard B Rothman, Eduardo R Butelman, Mary Jeanne Kreek, Thomas E Prisinzano
Bioorganic & Medicinal Chemistry May 1, 2012 DOI: 10.1016/j.bmc.2012.02.040 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Laboratory synthesis and receptor binding study Peer reviewed |
|---|---|
| Citations | 35 |
| Key points | A Liebeskind-Srogl cross-coupling reaction enables synthesis of C-12 ketone analogs of salvinorin A, and several new analogs retain affinity and selectivity at kappa opioid receptors. |
Abstract
Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors.
Citations in the library
Cited by 11
- Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands. Bioorganic & Medicinal Chemistry Letters May 15, 2013
- Neoclerodanes as atypical opioid receptor ligands. Journal of Medicinal Chemistry May 9, 2013
- Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs. Frontiers in Psychiatry 2019
- Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A Pharmaceuticals December 27, 2024
- A Route to Potent, Selective, and Biased Salvinorin Chemical Space. ACS Central Science August 23, 2023
and 6 more in the library
Cites 20
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum The Journal of Organic Chemistry November 1, 1984
- Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.). Journal of Ethnopharmacology May 1, 1983
- Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A. Journal of Psychoactive Drugs 1994
- Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors. Biochemistry June 21, 2005
and 15 more in the library